Evidence map›Paper›PMID 10419876›Full record

ReviewBlood1999

Adeno-associated virus vectors and hematology.

D W Russell, M A Kay

Abstract readReview
In one paragraph

Review in Blood, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities.International journal of molecular sciences · 2019
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Adeno-associated virus vector integration.Current opinion in molecular therapeutics · 2009
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.Transactions of the American Clinical and Climatological Association · 2003
    Review
  15. Hematopoietic stem cell gene therapy.International journal of hematology · 2002
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

D W RussellMarkey Molecular Medicine Center, Department of Medicine, University of Washington, Seattle, WA, USA. drussell@u.washington.edu
M A Kay

Funding

VECTOR CONSTRUCTIONS FOR GENE THERAPY OF SICKLE CELL DISEASEP01HL053750 · NHLBI · UNIVERSITY OF WASHINGTON · PI RUSSELL, DAVID W · 1994 to 2014
$30.4M
GENE TARGETING BY VIRAL VECTORSR01DK055759 · NIDDK · UNIVERSITY OF WASHINGTON · PI RUSSELL, DAVID W · 1999 to 2017
$5.8M
HEPATIC GENE TRANSFER FOR THE TREATMENT OF HEMOPHILIA BR01HL053682 · NHLBI · UNIVERSITY OF WASHINGTON · PI KAY, MARK A · 1995 to 1999
–
NHLBI NIH HHS HL53682NHLBI NIH HHS HL53750NHLBI NIH HHS P01 HL053750NHLBI NIH HHS R01 HL053682NIDDK NIH HHS R01 DK055759
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic TherapyGenetic VectorsGene Transfer TechniquesAnimalsDependovirusHematologic DiseasesHumans

Identifiers

PMID10419876
PMCPMC3739711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.